Members of the Simmons & Simmons international practice examine a UK Supreme Court decision on inventor compensation and compare how courts across Europe and in China are approaching similar situations
Pharma companies say AI’s potential to make R&D models more efficient and less expensive will drive the development of therapeutics that require different IP strategies
An exclusive interview with Justice Huber of the German Federal Constitutional Court and the results of our survey on mental health and wellbeing were among the most read
